These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28093485)

  • 1. Molecular insights into fosfomycin resistance in Escherichia coli.
    Ballestero-Téllez M; Docobo-Pérez F; Portillo-Calderón I; Rodríguez-Martínez JM; Racero L; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2017 May; 72(5):1303-1309. PubMed ID: 28093485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
    Takahata S; Ida T; Hiraishi T; Sakakibara S; Maebashi K; Terada S; Muratani T; Matsumoto T; Nakahama C; Tomono K
    Int J Antimicrob Agents; 2010 Apr; 35(4):333-7. PubMed ID: 20071153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa.
    Castañeda-García A; Rodríguez-Rojas A; Guelfo JR; Blázquez J
    J Bacteriol; 2009 Nov; 191(22):6968-74. PubMed ID: 19734311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions.
    Kurabayashi K; Tanimoto K; Fueki S; Tomita H; Hirakawa H
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6352-60. PubMed ID: 26248376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan.
    Tseng SP; Wang SF; Kuo CY; Huang JW; Hung WC; Ke GM; Lu PL
    PLoS One; 2015; 10(8):e0135864. PubMed ID: 26280832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.
    Lucas AE; Ito R; Mustapha MM; McElheny CL; Mettus RT; Bowler SL; Kantz SF; Pacey MP; Pasculle AW; Cooper VS; Doi Y
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29093108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How is fosfomycin resistance developed in Escherichia coli?
    Cattoir V; Guérin F
    Future Microbiol; 2018 Dec; 13():1693-1696. PubMed ID: 30526061
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China.
    Li Y; Zheng B; Li Y; Zhu S; Xue F; Liu J
    PLoS One; 2015; 10(8):e0135269. PubMed ID: 26252888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of
    Hirakawa H; Takita A; Sato Y; Hiramoto S; Hashimoto Y; Ohshima N; Minamishima YA; Murakami M; Tomita H
    Microbiol Spectr; 2023 Jun; 11(3):e0506922. PubMed ID: 37199605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of Reduced Susceptibility to Fosfomycin in
    Ohkoshi Y; Sato T; Suzuki Y; Yamamoto S; Shiraishi T; Ogasawara N; Yokota SI
    Biomed Res Int; 2017; 2017():5470241. PubMed ID: 28197413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae.
    Liu P; Chen S; Wu ZY; Qi M; Li XY; Liu CX
    J Glob Antimicrob Resist; 2020 Sep; 22():238-243. PubMed ID: 32061879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the Transporter Proteins GlpT and UhpT Confer Fosfomycin Resistance in
    Xu S; Fu Z; Zhou Y; Liu Y; Xu X; Wang M
    Front Microbiol; 2017; 8():914. PubMed ID: 28579984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Low-Level Fosfomycin-Resistant Variants by Decreasing Glucose-6-Phosphate Concentration in Fosfomycin Susceptibility Determination.
    Martín-Gutiérrez G; Docobo-Pérez F; Rodríguez-Martínez JM; Pascual A; Blázquez J; Rodriguez-Beltrán J
    Antibiotics (Basel); 2020 Nov; 9(11):. PubMed ID: 33198311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological costs and mechanisms of fosfomycin resistance in Escherichia coli.
    Nilsson AI; Berg OG; Aspevall O; Kahlmeter G; Andersson DI
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2850-8. PubMed ID: 12936984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Fosfomycin Resistance and Mutations in murA, glpT, and uhpT in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Blood and Cerebrospinal Fluid Samples.
    Fu Z; Ma Y; Chen C; Guo Y; Hu F; Liu Y; Xu X; Wang M
    Front Microbiol; 2015; 6():1544. PubMed ID: 26793179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyclonal Spread of Fosfomycin Resistance among Carbapenemase-Producing Members of the
    Mattioni Marchetti V; Kraftova L; Finianos M; Sourenian T; Hrabak J; Bitar I
    Microbiol Spectr; 2023 Jun; 11(3):e0009523. PubMed ID: 37098942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriological and molecular study of fosfomycin resistance in uropathogenic Escherichia coli.
    Ibrahim AA; Mohammed RK
    Braz J Microbiol; 2024 Jun; 55(2):1091-1097. PubMed ID: 38367167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-wide analysis of Escherichia coli responses to fosfomycin using TraDIS-Xpress reveals novel roles for phosphonate degradation and phosphate transport systems.
    Turner AK; Yasir M; Bastkowski S; Telatin A; Page AJ; Charles IG; Webber MA
    J Antimicrob Chemother; 2020 Nov; 75(11):3144-3151. PubMed ID: 32756955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative Actions of CRP-cAMP and FNR Increase the Fosfomycin Susceptibility of Enterohaemorrhagic
    Kurabayashi K; Tanimoto K; Tomita H; Hirakawa H
    Front Microbiol; 2017; 8():426. PubMed ID: 28360903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.